Profil
Per Gunnar Fernström currently works at Chalmers Industriteknik AB, as Chairman, InnovationsKapital Nordic Advisors AB, as Investment Director from 1998, Scienta Scientific AB, as Director, PBM Sweden AB, as Director, Stayble Therapeutics AB, as Director from 2021, Aqua Robur Technologies AB, as Director, and Besedo AB, as Director.
Mr. Fernström also formerly worked at Upfront Chromatography A, as Chairman, Cellectricon AB, as Director, Novavax AB, as Director, Roche Innovation Center Copenhagen A, as Director, Ludesi AB, as Director, Action Pharma A, as Director, BONESUPPORT HOLDING AB, as Director, 21 Grams AB, as Director, Takara Bio Europe AB, as Director, Chalmers Innovation, as Director, Medius AB, as Director, and SCA Molnlycke Clinical Products AB, as Executive Vice President.
Mr. Fernström received his graduate degree from Chalmers University of Technology and graduate degree from International Institute for Management Development.
Postes actifs de Per Gunnar Fernström
| Sociétés | Poste | Début |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Directeur/Membre du Conseil | 30/06/2021 |
InnovationsKapital Nordic Advisors AB
InnovationsKapital Nordic Advisors AB Investment ManagersFinance InnovationsKapital is an active, long-term manager which invests in start-up, early-stage or early expansion stage companies in the ICT, healthcare & life sciences and clean tech sectors in Sweden, Denmark, Finland and Norway, with a special emphasis on the commercial development of leading edge scientific research by high growth technology companies. The firm seeks to invest in companies with high-growth, innovative technology and well-focused businesses and the ability to create dominant or defensible market positions, evaluating all investment proposals based on the quality of the investee company management and board, the market opportunity and the uniqueness of the firm's technology. InnovationsKapital typically seeks a position on the investee company's board of directors, partnering with management to create value by developing sound corporate and product strategies and plans, expanding into international markets, building an industry network, supporting their growth, identifying and recruiting experienced board members and professional advisors, raising new financing and preparing the company for an IPO. | Head-Equity Investments | 01/03/1998 |
Chalmers Industriteknik AB | Président | - |
Besedo AB | Directeur/Membre du Conseil | - |
Aqua Robur Technologies AB
Aqua Robur Technologies AB Electronic Equipment/InstrumentsElectronic Technology Provides water leakage detection systems | Directeur/Membre du Conseil | - |
Scienta Scientific AB
Scienta Scientific AB Electronic Equipment/InstrumentsElectronic Technology Engages in research, development and application of applied nuclear, atomic and surface physics | Directeur/Membre du Conseil | - |
PBM Sweden AB
PBM Sweden AB Medical/Nursing ServicesHealth Services Provides behavioral psychology treatment services | Directeur/Membre du Conseil | - |
Anciens postes connus de Per Gunnar Fernström
| Sociétés | Poste | Fin |
|---|---|---|
Chalmers Innovation
Chalmers Innovation Investment ManagersFinance Chalmers' investment strategy focuses on generating growth and acting as a business incubator in the Nordic region. The firm looks for early-stage ideas and projects primarily in the technology sector which display significant global market potential. They manage a three-stage business development process: pre-incubator, incubator, and growth generator. In the pre-incubator phase, Chalmers can invest up to SEK 300 thousand in business ideas. In the incubator stage, they can invest an additional SEK 300 thousand. Subsequently, Chalmers works closely with the portfolio firms' founders and other investment partners, from either the public or private sector, to develop rapid growth in the new businesses. They also consider young firms that are already established in new markets and require growth capital to double their turnover. They are active owners drawing on their in-house expertise as well as leveraging their wide network. | Directeur/Membre du Conseil | - |
Upfront Chromatography A/S
Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Provides technology that isolates and purifies soluble proteins from industrial process streams | Président | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Per Gunnar Fernström
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
SCA Molnlycke Clinical Products AB
SCA Molnlycke Clinical Products AB Medical SpecialtiesHealth Technology Provides medical and clinical products | Health Technology |
InnovationsKapital Nordic Advisors AB
InnovationsKapital Nordic Advisors AB Investment ManagersFinance InnovationsKapital is an active, long-term manager which invests in start-up, early-stage or early expansion stage companies in the ICT, healthcare & life sciences and clean tech sectors in Sweden, Denmark, Finland and Norway, with a special emphasis on the commercial development of leading edge scientific research by high growth technology companies. The firm seeks to invest in companies with high-growth, innovative technology and well-focused businesses and the ability to create dominant or defensible market positions, evaluating all investment proposals based on the quality of the investee company management and board, the market opportunity and the uniqueness of the firm's technology. InnovationsKapital typically seeks a position on the investee company's board of directors, partnering with management to create value by developing sound corporate and product strategies and plans, expanding into international markets, building an industry network, supporting their growth, identifying and recruiting experienced board members and professional advisors, raising new financing and preparing the company for an IPO. | Finance |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Health Technology |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Upfront Chromatography A/S
Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Provides technology that isolates and purifies soluble proteins from industrial process streams | Commercial Services |
Ludesi AB
Ludesi AB Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics solutions to the life science industry | Commercial Services |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
BONESUPPORT HOLDING AB
BONESUPPORT HOLDING AB Medical SpecialtiesHealth Technology Develops and sells injectable, synthetic ceramic bone substitutes and injection accessories | Health Technology |
21 Grams AB
21 Grams AB Miscellaneous Commercial ServicesCommercial Services Provides postal management services | Commercial Services |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Chalmers Innovation
Chalmers Innovation Investment ManagersFinance Chalmers' investment strategy focuses on generating growth and acting as a business incubator in the Nordic region. The firm looks for early-stage ideas and projects primarily in the technology sector which display significant global market potential. They manage a three-stage business development process: pre-incubator, incubator, and growth generator. In the pre-incubator phase, Chalmers can invest up to SEK 300 thousand in business ideas. In the incubator stage, they can invest an additional SEK 300 thousand. Subsequently, Chalmers works closely with the portfolio firms' founders and other investment partners, from either the public or private sector, to develop rapid growth in the new businesses. They also consider young firms that are already established in new markets and require growth capital to double their turnover. They are active owners drawing on their in-house expertise as well as leveraging their wide network. | Finance |
Scienta Scientific AB
Scienta Scientific AB Electronic Equipment/InstrumentsElectronic Technology Engages in research, development and application of applied nuclear, atomic and surface physics | Electronic Technology |
Medius AB
Medius AB Packaged SoftwareTechnology Services Develops AI-powered software platform to link and automate invoice capture, processing & payments for mid-market and enterprise AP teams | Technology Services |
PBM Sweden AB
PBM Sweden AB Medical/Nursing ServicesHealth Services Provides behavioral psychology treatment services | Health Services |
Chalmers Industriteknik AB | |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
Aqua Robur Technologies AB
Aqua Robur Technologies AB Electronic Equipment/InstrumentsElectronic Technology Provides water leakage detection systems | Electronic Technology |
Besedo AB |
















